Review





Similar Products

86
Galectin Therapeutics d j galectin 1 protein therapy prevents pathology
D J Galectin 1 Protein Therapy Prevents Pathology, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/lgals3/pm42284448-362-15-17
Average 86 stars, based on 1 article reviews
d j galectin 1 protein therapy prevents pathology - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Westat Inc plasma protein therapeutics association ppta
Plasma Protein Therapeutics Association Ppta, supplied by Westat Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/association+plasma+ppta+protein+therapeutics/pm42312388-7890-4-3
Average 86 stars, based on 1 article reviews
plasma protein therapeutics association ppta - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Brennen Medical Inc fibroblast activation protein targeted therapy
Fibroblast Activation Protein Targeted Therapy, supplied by Brennen Medical Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/activation+fibroblast+protein+targeted+therapy/pm42071201-1795-22-0
Average 86 stars, based on 1 article reviews
fibroblast activation protein targeted therapy - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

96
R&D Systems recombinant ifn treatment
Recombinant Ifn Treatment, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/Recombinant+Human+IFN-beta+Protein/pm42012182-194-1-27
Average 96 stars, based on 1 article reviews
recombinant ifn treatment - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
TargetMol nek8 inhibitor treatment
Nek8 Inhibitor Treatment, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/NEK9+Protein%2C+Human%2C+Recombinant/pm41904143-339-2-9
Average 94 stars, based on 1 article reviews
nek8 inhibitor treatment - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

97
R&D Systems interferon gamma treatment
Interferon Gamma Treatment, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/Recombinant+Human+IFN-gamma+Protein/us12584144-920-22-26
Average 97 stars, based on 1 article reviews
interferon gamma treatment - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

96
R&D Systems ifnγ treatment
( a ) GF <t>colonic</t> <t>organoids</t> treated with increasing concentration of <t>IFNγ</t> for 48 h. Low-dose IFNγ (0.1 ng/ml) had minimal effects on organoid proliferation and viability. Representative bright-field images show dose-dependent morphological changes. PBS, phosphate-buffered saline. Scale bars, 500 μm. ( b ) ChIP-qPCR analysis of GF colonic organoids treated with 0.1 ng/ml IFNγ to induce demethylation of the Cd74 enhancer. Binding of STAT and TET family members was assessed at the enhancer regions showing demethylation (ChIP-2 and ChIP-3) and at a non-DMR control region (ChIP-1). STAT1, TET1, and TET2 showed no detectable enrichment at the demethylated enhancer regions relative to the control. Data are presented as mean ± s.e.m. of 4 independent experiments. P values were calculated using unpaired (two-tailed) t -test.
Ifnγ Treatment, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+therapeutics/Recombinant+Mouse+IFN-gamma+Protein/pmc13056565-229-1-11
Average 96 stars, based on 1 article reviews
ifnγ treatment - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


( a ) GF colonic organoids treated with increasing concentration of IFNγ for 48 h. Low-dose IFNγ (0.1 ng/ml) had minimal effects on organoid proliferation and viability. Representative bright-field images show dose-dependent morphological changes. PBS, phosphate-buffered saline. Scale bars, 500 μm. ( b ) ChIP-qPCR analysis of GF colonic organoids treated with 0.1 ng/ml IFNγ to induce demethylation of the Cd74 enhancer. Binding of STAT and TET family members was assessed at the enhancer regions showing demethylation (ChIP-2 and ChIP-3) and at a non-DMR control region (ChIP-1). STAT1, TET1, and TET2 showed no detectable enrichment at the demethylated enhancer regions relative to the control. Data are presented as mean ± s.e.m. of 4 independent experiments. P values were calculated using unpaired (two-tailed) t -test.

Journal: Nature Microbiology

Article Title: Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice

doi: 10.1038/s41564-026-02295-6

Figure Lengend Snippet: ( a ) GF colonic organoids treated with increasing concentration of IFNγ for 48 h. Low-dose IFNγ (0.1 ng/ml) had minimal effects on organoid proliferation and viability. Representative bright-field images show dose-dependent morphological changes. PBS, phosphate-buffered saline. Scale bars, 500 μm. ( b ) ChIP-qPCR analysis of GF colonic organoids treated with 0.1 ng/ml IFNγ to induce demethylation of the Cd74 enhancer. Binding of STAT and TET family members was assessed at the enhancer regions showing demethylation (ChIP-2 and ChIP-3) and at a non-DMR control region (ChIP-1). STAT1, TET1, and TET2 showed no detectable enrichment at the demethylated enhancer regions relative to the control. Data are presented as mean ± s.e.m. of 4 independent experiments. P values were calculated using unpaired (two-tailed) t -test.

Article Snippet: For IFNγ treatment, GF-derived organoids were incubated with recombinant mouse IFNγ (R&D Systems, 485-MI-100) at 0.1 ng ml −1 for 0, 24, 48, 72 or 96 h before collection.

Techniques: Concentration Assay, Saline, ChIP-qPCR, Binding Assay, Control, Two Tailed Test

a , Time-course analysis of Cd74 methylation and expression in GF colonic organoids treated with a low dose of IFNγ (0.1 ng ml −1 ) demonstrates rapid demethylation and concomitant gene activation. Data are presented as mean ± s.e.m. of 2 independent experiments. b , DNA demethylase TET3 mediates IFNγ-induced epigenetic reprogramming of Cd74 . Shown is the Cd74 locus with its genomic location, ATAC-seq peaks from sorted Lgr5-GFP + ISCs ( GSE83394 ), the microbial-induced DMR (dashed box) and the positions of primer sets used to assess STATs and TETs binding by ChIP–qPCR. Compared with a non-DMR control region (ChIP-1), STAT3 and TET3 showed an IFNγ-dependent increase in binding at the DMR/enhancer (ChIP-2 and ChIP-3). c , Combined treatment with IFNγ and the hypomethylation agent DAC synergistically enhanced IFNγ-induced demethylation and transcriptional activation. In contrast, treatment with TNF, sodium butyrate (NaB) or LPS alone did not alter Cd74 methylation. d , Experimental design for testing transcriptional memory in organoids with (primed) or without (naïve) previous IFNγ exposure. Pretreated organoids were rested for 7 days without IFNγ and then restimulated with IFNγ or TNF. Memory was indicated by faster and stronger induction of Cd74 expression. e , Before restimulation, organoids exposed to IFNγ for 3 passages (primed) showed nearly complete loss of Cd74 methylation. f , IFNγ (left) or TNF (right) restimulation of primed organoids accelerated and enhanced Cd74 expression compared to naïve organoids. g , Experimental design to determine whether microbiota drive methylation-dependent transcriptional memory of epithelial MHC-II. h , Methylation of MHC-II genes in organoids derived from adult GF, SPF and GF→ SPF (converted at weaning) mice at 15 weeks of age, with methylation assessed after passage 2. i , IFNγ stimulation induced methylation-dependent, memory-like transcriptional activation of the MHC-II genes Cd74 , H2-Eb1 , H2-Aa and Ciita in SPF and GF→ SPF organoids, measured by RT–qPCR. In b , c , e , f , h and i , all data are presented as mean ± s.e.m. of at least 3 independent experiments. In b , c , e and h , P values were calculated using unpaired (two-tailed) t -test.

Journal: Nature Microbiology

Article Title: Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice

doi: 10.1038/s41564-026-02295-6

Figure Lengend Snippet: a , Time-course analysis of Cd74 methylation and expression in GF colonic organoids treated with a low dose of IFNγ (0.1 ng ml −1 ) demonstrates rapid demethylation and concomitant gene activation. Data are presented as mean ± s.e.m. of 2 independent experiments. b , DNA demethylase TET3 mediates IFNγ-induced epigenetic reprogramming of Cd74 . Shown is the Cd74 locus with its genomic location, ATAC-seq peaks from sorted Lgr5-GFP + ISCs ( GSE83394 ), the microbial-induced DMR (dashed box) and the positions of primer sets used to assess STATs and TETs binding by ChIP–qPCR. Compared with a non-DMR control region (ChIP-1), STAT3 and TET3 showed an IFNγ-dependent increase in binding at the DMR/enhancer (ChIP-2 and ChIP-3). c , Combined treatment with IFNγ and the hypomethylation agent DAC synergistically enhanced IFNγ-induced demethylation and transcriptional activation. In contrast, treatment with TNF, sodium butyrate (NaB) or LPS alone did not alter Cd74 methylation. d , Experimental design for testing transcriptional memory in organoids with (primed) or without (naïve) previous IFNγ exposure. Pretreated organoids were rested for 7 days without IFNγ and then restimulated with IFNγ or TNF. Memory was indicated by faster and stronger induction of Cd74 expression. e , Before restimulation, organoids exposed to IFNγ for 3 passages (primed) showed nearly complete loss of Cd74 methylation. f , IFNγ (left) or TNF (right) restimulation of primed organoids accelerated and enhanced Cd74 expression compared to naïve organoids. g , Experimental design to determine whether microbiota drive methylation-dependent transcriptional memory of epithelial MHC-II. h , Methylation of MHC-II genes in organoids derived from adult GF, SPF and GF→ SPF (converted at weaning) mice at 15 weeks of age, with methylation assessed after passage 2. i , IFNγ stimulation induced methylation-dependent, memory-like transcriptional activation of the MHC-II genes Cd74 , H2-Eb1 , H2-Aa and Ciita in SPF and GF→ SPF organoids, measured by RT–qPCR. In b , c , e , f , h and i , all data are presented as mean ± s.e.m. of at least 3 independent experiments. In b , c , e and h , P values were calculated using unpaired (two-tailed) t -test.

Article Snippet: For IFNγ treatment, GF-derived organoids were incubated with recombinant mouse IFNγ (R&D Systems, 485-MI-100) at 0.1 ng ml −1 for 0, 24, 48, 72 or 96 h before collection.

Techniques: Methylation, Expressing, Activation Assay, Binding Assay, ChIP-qPCR, Control, Derivative Assay, Quantitative RT-PCR, Two Tailed Test

( a ) Representative images show comparable proliferation and viability following IFNγ treatment in organoids derived from GF, SPF, or GF→ SPF (converted at weaning) mice. Scale bars, 500 μm. ( b ) 6 h post-treatment, MHC-II gene activation was enhanced only in organoids from mice with prior microbial exposure, indicating that induction is microbiota- and methylation-dependent, and not due to changes in proliferation. Data are presented as mean ± s.e.m. of 3 independent experiments. P values were calculated using unpaired (two-tailed) t -test.

Journal: Nature Microbiology

Article Title: Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice

doi: 10.1038/s41564-026-02295-6

Figure Lengend Snippet: ( a ) Representative images show comparable proliferation and viability following IFNγ treatment in organoids derived from GF, SPF, or GF→ SPF (converted at weaning) mice. Scale bars, 500 μm. ( b ) 6 h post-treatment, MHC-II gene activation was enhanced only in organoids from mice with prior microbial exposure, indicating that induction is microbiota- and methylation-dependent, and not due to changes in proliferation. Data are presented as mean ± s.e.m. of 3 independent experiments. P values were calculated using unpaired (two-tailed) t -test.

Article Snippet: For IFNγ treatment, GF-derived organoids were incubated with recombinant mouse IFNγ (R&D Systems, 485-MI-100) at 0.1 ng ml −1 for 0, 24, 48, 72 or 96 h before collection.

Techniques: Derivative Assay, Activation Assay, Methylation, Two Tailed Test